ReP USP - Resultado da busca

Artigo de periodico
Development and evaluation of nanostructured systems for cutaneous delivery of H2S-releasing corticosteroids for skin inflammatory diseases (2024)
Miranda, Daniel Augusto Gomes ; Cerqueira, Anderson Romério Azevedo ; Severino, Beatrice ; Caliendo, Giuseppe ; Corvino, Angela ; Andreozzi, Giorgia; Scognamiglio, Antonia ; Chorilli, Marlus ; Frecentese, Francesco ; Muscará, Marcelo Nicolas ; Costa, Soraia Katia Pereira ; Lopes, Luciana Biagini
Source: European Journal of Pharmaceutical Sciences. Unidade: ICB
Subjects: FARMACOLOGIA, PSORÍASE, DOENÇAS DA PELE E DO TECIDO CONJUNTIVO, ANTI-INFLAMATÓRIOS, MATERIAIS NANOESTRUTURADOS, HORMÔNIOS GLICOCORTICOIDES, HORMÔNIOS DO CÓRTEX ADRENAL, PELE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIRANDA, Daniel Augusto Gomes et al. Development and evaluation of nanostructured systems for cutaneous delivery of H2S-releasing corticosteroids for skin inflammatory diseases. European Journal of Pharmaceutical Sciences, v. 203, p. 10 , 2024Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2024.106925. Acesso em: 01 jul. 2025.
APA
Miranda, D. A. G., Cerqueira, A. R. A., Severino, B., Caliendo, G., Corvino, A., Andreozzi, G., et al. (2024). Development and evaluation of nanostructured systems for cutaneous delivery of H2S-releasing corticosteroids for skin inflammatory diseases. European Journal of Pharmaceutical Sciences, 203, 10 . doi:10.1016/j.ejps.2024.106925
NLM
Miranda DAG, Cerqueira ARA, Severino B, Caliendo G, Corvino A, Andreozzi G, Scognamiglio A, Chorilli M, Frecentese F, Muscará MN, Costa SKP, Lopes LB. Development and evaluation of nanostructured systems for cutaneous delivery of H2S-releasing corticosteroids for skin inflammatory diseases [Internet]. European Journal of Pharmaceutical Sciences. 2024 ; 203 10 .[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2024.106925
Vancouver
Miranda DAG, Cerqueira ARA, Severino B, Caliendo G, Corvino A, Andreozzi G, Scognamiglio A, Chorilli M, Frecentese F, Muscará MN, Costa SKP, Lopes LB. Development and evaluation of nanostructured systems for cutaneous delivery of H2S-releasing corticosteroids for skin inflammatory diseases [Internet]. European Journal of Pharmaceutical Sciences. 2024 ; 203 10 .[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2024.106925
Artigo de periodico
Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer (2023)
Fukumori, Claudio ; Branco, Paola Cristina ; Barreto, Thayná ; Ishida, Kelly ; Lopes, Luciana Biagini
Source: European Journal of Pharmaceutical Sciences. Unidade: ICB
Subjects: FARMACOLOGIA, MICROBIOLOGIA, NEOPLASIAS COLORRETAIS, ANTINEOPLÁSICOS, QUIMIOTERAPIA, CITOTOXINAS, GORDURAS, ALGINATOS, MUTAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUKUMORI, Claudio et al. Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer. European Journal of Pharmaceutical Sciences, v. 187, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2023.106465. Acesso em: 01 jul. 2025.
APA
Fukumori, C., Branco, P. C., Barreto, T., Ishida, K., & Lopes, L. B. (2023). Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer. European Journal of Pharmaceutical Sciences, 187, 1-15. doi:10.1016/j.ejps.2023.106465
NLM
Fukumori C, Branco PC, Barreto T, Ishida K, Lopes LB. Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer [Internet]. European Journal of Pharmaceutical Sciences. 2023 ; 187 1-15.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2023.106465
Vancouver
Fukumori C, Branco PC, Barreto T, Ishida K, Lopes LB. Development and cytotoxicity evaluation of multiple nanoemulsions for oral co-delivery of 5-fluorouracil and short chain triglycerides for colorectal cancer [Internet]. European Journal of Pharmaceutical Sciences. 2023 ; 187 1-15.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2023.106465
Artigo de periodico
Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase (2023)
Miguel, Rodrigo dos Anjos ; Hirata, Amanda Soares ; Salata, Giovanna Cassone ; Apolinário, Alexsandra Conceição ; Barroso, Vinícius de Morais ; Clair, James J. La ; Fenical, William ; Martins, Tereza Silva ; Costa-Lotufo, Letícia Veras ; Ishida, Kelly ; Lopes, Luciana Biagini
Source: European Journal of Pharmaceutical Sciences. Unidade: ICB
Subjects: MICROBIOLOGIA, FARMACOLOGIA, CÉLULAS CULTIVADAS DE TUMOR, NEOPLASIAS CUTÂNEAS, ANTINEOPLÁSICOS, MELANOMA, ANIMAIS, CANDIDA ALBICANS, MICOSES, PELE, NANOTECNOLOGIA, ANTIFÚNGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIGUEL, Rodrigo dos Anjos et al. Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase. European Journal of Pharmaceutical Sciences, v. 192, p. 14 , 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2023.106635. Acesso em: 01 jul. 2025.
APA
Miguel, R. dos A., Hirata, A. S., Salata, G. C., Apolinário, A. C., Barroso, V. de M., Clair, J. J. L., et al. (2023). Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase. European Journal of Pharmaceutical Sciences, 192, 14 . doi:10.1016/j.ejps.2023.106635
NLM
Miguel R dos A, Hirata AS, Salata GC, Apolinário AC, Barroso V de M, Clair JJL, Fenical W, Martins TS, Costa-Lotufo LV, Ishida K, Lopes LB. Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase [Internet]. European Journal of Pharmaceutical Sciences. 2023 ; 192 14 .[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2023.106635
Vancouver
Miguel R dos A, Hirata AS, Salata GC, Apolinário AC, Barroso V de M, Clair JJL, Fenical W, Martins TS, Costa-Lotufo LV, Ishida K, Lopes LB. Topical delivery of seriniquinone for treatment of skin cancer and fungal infections is enabled by a liquid crystalline lamellar phase [Internet]. European Journal of Pharmaceutical Sciences. 2023 ; 192 14 .[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2023.106635
Artigo de periodico
Nanostructured lipid carriers loaded into in situ gels for breast cancer local treatment (2023)
Passos, Julia Sapienza ; Apolinário, Alexsandra Conceição ; Martins, Tereza Silva ; Ishida, Kelly ; Lopes, Luciana Biagini
Source: European Journal of Pharmaceutical Sciences. Unidade: ICB
Subjects: MICROBIOLOGIA, FARMACOLOGIA, NEOPLASIAS MAMÁRIAS, NANOPARTÍCULAS, LIPÍDEOS, GEL (FORMAS FARMACÊUTICAS), FÁRMACOS, CITOTOXICIDADE IMUNOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASSOS, Julia Sapienza et al. Nanostructured lipid carriers loaded into in situ gels for breast cancer local treatment. European Journal of Pharmaceutical Sciences, v. 192, p. 18 , 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2023.106638. Acesso em: 01 jul. 2025.
APA
Passos, J. S., Apolinário, A. C., Martins, T. S., Ishida, K., & Lopes, L. B. (2023). Nanostructured lipid carriers loaded into in situ gels for breast cancer local treatment. European Journal of Pharmaceutical Sciences, 192, 18 . doi:10.1016/j.ejps.2023.106638
NLM
Passos JS, Apolinário AC, Martins TS, Ishida K, Lopes LB. Nanostructured lipid carriers loaded into in situ gels for breast cancer local treatment [Internet]. European Journal of Pharmaceutical Sciences. 2023 ; 192 18 .[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2023.106638
Vancouver
Passos JS, Apolinário AC, Martins TS, Ishida K, Lopes LB. Nanostructured lipid carriers loaded into in situ gels for breast cancer local treatment [Internet]. European Journal of Pharmaceutical Sciences. 2023 ; 192 18 .[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2023.106638
Artigo de periodico
Assessment of the impact of partial area under the curve in a bioavailability/bioequivalence study on generic prolonged-release formulations (2022)
Soares, Kelen Carine Costa; Chiann, Chang ; Storpirtis, Silvia
Source: European Journal of Pharmaceutical Sciences. Unidades: IME, FCF
Subjects: BIOEQUIVALÊNCIA, ANÁLISE DE SÉRIES TEMPORAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Kelen Carine Costa e CHIANN, Chang e STORPIRTIS, Silvia. Assessment of the impact of partial area under the curve in a bioavailability/bioequivalence study on generic prolonged-release formulations. European Journal of Pharmaceutical Sciences, v. 171, n. artigo 106127, p. 1-6, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2022.106127. Acesso em: 01 jul. 2025.
APA
Soares, K. C. C., Chiann, C., & Storpirtis, S. (2022). Assessment of the impact of partial area under the curve in a bioavailability/bioequivalence study on generic prolonged-release formulations. European Journal of Pharmaceutical Sciences, 171( artigo 106127), 1-6. doi:10.1016/j.ejps.2022.106127
NLM
Soares KCC, Chiann C, Storpirtis S. Assessment of the impact of partial area under the curve in a bioavailability/bioequivalence study on generic prolonged-release formulations [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 171( artigo 106127): 1-6.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2022.106127
Vancouver
Soares KCC, Chiann C, Storpirtis S. Assessment of the impact of partial area under the curve in a bioavailability/bioequivalence study on generic prolonged-release formulations [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 171( artigo 106127): 1-6.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2022.106127
Artigo de periodico
Pharmacokinetic study of AmB-NP-GR: a new granule form with amphotericin B to treat leishmaniasis and fungal infections (2022)
Tadini, Maraine Catarina ; Fernandes, Fernanda Santos; Ozelin, Saulo Duarte; Melo, Matheus Reis Santos de; Mansur, Ana Luiza; Toledo, Thaís Bueno de; Albuquerque, Nayara Cristina Perez de; Tavares, Denise Crispim; Marquele Oliveira, Franciane; Oliveira, Anderson Rodrigo Moraes de
Source: European Journal of Pharmaceutical Sciences. Unidade: FFCLRP
Subjects: ANTIFÚNGICOS, LEISHMANIOSE CUTÂNEA, FARMACOTERAPIA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TADINI, Maraine Catarina et al. Pharmacokinetic study of AmB-NP-GR: a new granule form with amphotericin B to treat leishmaniasis and fungal infections. European Journal of Pharmaceutical Sciences, v. 173, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2022.106173. Acesso em: 01 jul. 2025.
APA
Tadini, M. C., Fernandes, F. S., Ozelin, S. D., Melo, M. R. S. de, Mansur, A. L., Toledo, T. B. de, et al. (2022). Pharmacokinetic study of AmB-NP-GR: a new granule form with amphotericin B to treat leishmaniasis and fungal infections. European Journal of Pharmaceutical Sciences, 173, 1-9. doi:10.1016/j.ejps.2022.106173
NLM
Tadini MC, Fernandes FS, Ozelin SD, Melo MRS de, Mansur AL, Toledo TB de, Albuquerque NCP de, Tavares DC, Marquele Oliveira F, Oliveira ARM de. Pharmacokinetic study of AmB-NP-GR: a new granule form with amphotericin B to treat leishmaniasis and fungal infections [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 173 1-9.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2022.106173
Vancouver
Tadini MC, Fernandes FS, Ozelin SD, Melo MRS de, Mansur AL, Toledo TB de, Albuquerque NCP de, Tavares DC, Marquele Oliveira F, Oliveira ARM de. Pharmacokinetic study of AmB-NP-GR: a new granule form with amphotericin B to treat leishmaniasis and fungal infections [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 173 1-9.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2022.106173
Artigo de periodico
Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum (2022)
Monteiro, Lis Marie ; Löbenberg, Raimar ; Barbosa, Eduardo José ; Araujo, Gabriel Lima Barros de ; Sato, Paula Keiko ; Kanashiro, Edite Hatsumi Yamashiro ; Eliodoro, Raissa Heloisa de Araujo; Rocha, Mussya; Freitas, Vera Lucia Teixeira de ; Fotaki, Nikoletta; Bou-Chacra, Nadia Araci
Source: European Journal of Pharmaceutical Sciences. Unidades: FCF, IMT, FM
Subjects: LIPÍDEOS, LEISHMANIOSE VISCERAL, DOENÇAS NEGLIGENCIADAS, NANOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTEIRO, Lis Marie et al. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum. European Journal of Pharmaceutical Sciences, v. 169, p. 1-11 art. 106097, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2021.106097. Acesso em: 01 jul. 2025.
APA
Monteiro, L. M., Löbenberg, R., Barbosa, E. J., Araujo, G. L. B. de, Sato, P. K., Kanashiro, E. H. Y., et al. (2022). Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum. European Journal of Pharmaceutical Sciences, 169, 1-11 art. 106097. doi:10.1016/j.ejps.2021.106097
NLM
Monteiro LM, Löbenberg R, Barbosa EJ, Araujo GLB de, Sato PK, Kanashiro EHY, Eliodoro RH de A, Rocha M, Freitas VLT de, Fotaki N, Bou-Chacra NA. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 169 1-11 art. 106097.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2021.106097
Vancouver
Monteiro LM, Löbenberg R, Barbosa EJ, Araujo GLB de, Sato PK, Kanashiro EHY, Eliodoro RH de A, Rocha M, Freitas VLT de, Fotaki N, Bou-Chacra NA. Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum [Internet]. European Journal of Pharmaceutical Sciences. 2022 ; 169 1-11 art. 106097.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2021.106097
Artigo de periodico
Gold(III) complexes with thiosemicarbazonate ligands as potential anticancer agents: cytotoxicity and interactions with biomolecular targets (2021)
Possato, Bruna; Dalmolin, Luciana Facco; Pereira, Luiz Miguel; Alves, Jacqueline Querino; Silva, Raphael Tristão Cruvinel; Gelamo, Rogerio Valentim; Yatsuda, Ana Patrícia ; Lopez, Renata Fonseca Vianna ; Albuquerque, Sérgio de ; Leite, Natália Bueno; Maia, Pedro Ivo da Silva
Source: European Journal of Pharmaceutical Sciences. Unidades: FCFRP, PUSP-RP
Subjects: ANTINEOPLÁSICOS, APOPTOSE, LINHAGEM CELULAR, LIGANTES, NEOPLASIAS OVARIANAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POSSATO, Bruna et al. Gold(III) complexes with thiosemicarbazonate ligands as potential anticancer agents: cytotoxicity and interactions with biomolecular targets. European Journal of Pharmaceutical Sciences, v. 162, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2021.105834. Acesso em: 01 jul. 2025.
APA
Possato, B., Dalmolin, L. F., Pereira, L. M., Alves, J. Q., Silva, R. T. C., Gelamo, R. V., et al. (2021). Gold(III) complexes with thiosemicarbazonate ligands as potential anticancer agents: cytotoxicity and interactions with biomolecular targets. European Journal of Pharmaceutical Sciences, 162. doi:10.1016/j.ejps.2021.105834
NLM
Possato B, Dalmolin LF, Pereira LM, Alves JQ, Silva RTC, Gelamo RV, Yatsuda AP, Lopez RFV, Albuquerque S de, Leite NB, Maia PI da S. Gold(III) complexes with thiosemicarbazonate ligands as potential anticancer agents: cytotoxicity and interactions with biomolecular targets [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 162[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2021.105834
Vancouver
Possato B, Dalmolin LF, Pereira LM, Alves JQ, Silva RTC, Gelamo RV, Yatsuda AP, Lopez RFV, Albuquerque S de, Leite NB, Maia PI da S. Gold(III) complexes with thiosemicarbazonate ligands as potential anticancer agents: cytotoxicity and interactions with biomolecular targets [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 162[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2021.105834
Artigo de periodico
Hydroxypropyl methylcellulose: physicochemical properties and ocular drug delivery formulations (2021)
Tundisi, L. L; Mostaço, Guilherme Büttner ; Carricondo, Pedro Carlos ; Petri, Denise Freitas Siqueira
Source: European Journal of Pharmaceutical Sciences. Unidade: IQ
Subjects: ÉTER, CELULOSE, MEDICAMENTO, OLHO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TUNDISI, L. L et al. Hydroxypropyl methylcellulose: physicochemical properties and ocular drug delivery formulations. European Journal of Pharmaceutical Sciences, v. 159, p. 1-12 art. 105736, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2021.105736. Acesso em: 01 jul. 2025.
APA
Tundisi, L. L., Mostaço, G. B., Carricondo, P. C., & Petri, D. F. S. (2021). Hydroxypropyl methylcellulose: physicochemical properties and ocular drug delivery formulations. European Journal of Pharmaceutical Sciences, 159, 1-12 art. 105736. doi:10.1016/j.ejps.2021.105736
NLM
Tundisi LL, Mostaço GB, Carricondo PC, Petri DFS. Hydroxypropyl methylcellulose: physicochemical properties and ocular drug delivery formulations [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 159 1-12 art. 105736.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2021.105736
Vancouver
Tundisi LL, Mostaço GB, Carricondo PC, Petri DFS. Hydroxypropyl methylcellulose: physicochemical properties and ocular drug delivery formulations [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 159 1-12 art. 105736.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2021.105736
Artigo de periodico
Biodegradable electrospun nanofibers: a new approach for rhinosinusitis treatment (2021)
Rivelli, Graziella Gomes; Perez, André Coura; Silva, Pedro Henrique Reis; Gomes, Elionai Cassiana de Lima; Moreira, Carolina Paula de Souza; Tamashiro, Edwin ; Valera, Fabiana Cardoso Pereira ; Anselmo-Lima, Wilma Terezinha ; Pianetti, Gérson Antônio; Silva-Cunha, Armando
Source: European Journal of Pharmaceutical Sciences. Unidade: FMRP
Subjects: CALORÍMETROS, MICROSCOPIA, ELÉTRONS, MATERIAIS NANOESTRUTURADOS, POLÍMEROS (MATERIAIS), DIFRAÇÃO POR RAIOS X, SINUSITE CRÔNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIVELLI, Graziella Gomes et al. Biodegradable electrospun nanofibers: a new approach for rhinosinusitis treatment. European Journal of Pharmaceutical Sciences, v. 163, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2021.105852. Acesso em: 01 jul. 2025.
APA
Rivelli, G. G., Perez, A. C., Silva, P. H. R., Gomes, E. C. de L., Moreira, C. P. de S., Tamashiro, E., et al. (2021). Biodegradable electrospun nanofibers: a new approach for rhinosinusitis treatment. European Journal of Pharmaceutical Sciences, 163. doi:10.1016/j.ejps.2021.105852
NLM
Rivelli GG, Perez AC, Silva PHR, Gomes EC de L, Moreira CP de S, Tamashiro E, Valera FCP, Anselmo-Lima WT, Pianetti GA, Silva-Cunha A. Biodegradable electrospun nanofibers: a new approach for rhinosinusitis treatment [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 163[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2021.105852
Vancouver
Rivelli GG, Perez AC, Silva PHR, Gomes EC de L, Moreira CP de S, Tamashiro E, Valera FCP, Anselmo-Lima WT, Pianetti GA, Silva-Cunha A. Biodegradable electrospun nanofibers: a new approach for rhinosinusitis treatment [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 163[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2021.105852
Artigo de periodico
Ex vivo penetration analysis and anti-inflammatory efficacy of the association of ferulic acid and UV filters (2021)
Sauce, Rafael; Pinto, Claudinéia Aparecida Sales de Oliveira ; Velasco, Maria Valéria Robles ; Rosado, Catarina; Baby, André Rolim
Source: European Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: FILTRO SOLAR, ANTIOXIDANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAUCE, Rafael et al. Ex vivo penetration analysis and anti-inflammatory efficacy of the association of ferulic acid and UV filters. European Journal of Pharmaceutical Sciences, v. 156, p. 1-7 art. 105578, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2020.105578. Acesso em: 01 jul. 2025.
APA
Sauce, R., Pinto, C. A. S. de O., Velasco, M. V. R., Rosado, C., & Baby, A. R. (2021). Ex vivo penetration analysis and anti-inflammatory efficacy of the association of ferulic acid and UV filters. European Journal of Pharmaceutical Sciences, 156, 1-7 art. 105578. doi:10.1016/j.ejps.2020.105578
NLM
Sauce R, Pinto CAS de O, Velasco MVR, Rosado C, Baby AR. Ex vivo penetration analysis and anti-inflammatory efficacy of the association of ferulic acid and UV filters [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 156 1-7 art. 105578.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2020.105578
Vancouver
Sauce R, Pinto CAS de O, Velasco MVR, Rosado C, Baby AR. Ex vivo penetration analysis and anti-inflammatory efficacy of the association of ferulic acid and UV filters [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 156 1-7 art. 105578.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2020.105578
Artigo de periodico
Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug dacarbazine (2021)
Leite, Marcel Nani; Viegas, Juliana Santos Rosa ; Praça, Fabíola ; Paula, Natália Aparecida de ; Ramalho, Leandra Naíra Zambelli; Bentley, Maria Vitória Lopes Badra ; Frade, Marco Andrey Cipriani
Source: European Journal of Pharmaceutical Sciences. Unidades: FCFRP, FMRP
Subjects: FÁRMACOS, PELE, ANTINEOPLÁSICOS, FIBROBLASTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Marcel Nani et al. Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug dacarbazine. European Journal of Pharmaceutical Sciences, v. 160, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2021.105769. Acesso em: 01 jul. 2025.
APA
Leite, M. N., Viegas, J. S. R., Praça, F., Paula, N. A. de, Ramalho, L. N. Z., Bentley, M. V. L. B., & Frade, M. A. C. (2021). Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug dacarbazine. European Journal of Pharmaceutical Sciences, 160. doi:10.1016/j.ejps.2021.105769
NLM
Leite MN, Viegas JSR, Praça F, Paula NA de, Ramalho LNZ, Bentley MVLB, Frade MAC. Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug dacarbazine [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 160[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2021.105769
Vancouver
Leite MN, Viegas JSR, Praça F, Paula NA de, Ramalho LNZ, Bentley MVLB, Frade MAC. Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug dacarbazine [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 160[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2021.105769
Artigo de periodico
Anti-inflammatory drug nanocrystals: state of art and regulatory perspective (2021)
Macedo, Luiza Oliveira; Barbosa, Eduardo José ; Löbenberg, Raimar ; Bou-Chacra, Nadia Araci
Source: European Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: ANTI-INFLAMATÓRIOS NÃO ESTEROIDES, NANOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACEDO, Luiza Oliveira et al. Anti-inflammatory drug nanocrystals: state of art and regulatory perspective. European Journal of Pharmaceutical Sciences, v. 158, p. 1-15 art. 105654, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2020.105654. Acesso em: 01 jul. 2025.
APA
Macedo, L. O., Barbosa, E. J., Löbenberg, R., & Bou-Chacra, N. A. (2021). Anti-inflammatory drug nanocrystals: state of art and regulatory perspective. European Journal of Pharmaceutical Sciences, 158, 1-15 art. 105654. doi:10.1016/j.ejps.2020.105654
NLM
Macedo LO, Barbosa EJ, Löbenberg R, Bou-Chacra NA. Anti-inflammatory drug nanocrystals: state of art and regulatory perspective [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 158 1-15 art. 105654.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2020.105654
Vancouver
Macedo LO, Barbosa EJ, Löbenberg R, Bou-Chacra NA. Anti-inflammatory drug nanocrystals: state of art and regulatory perspective [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 158 1-15 art. 105654.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2020.105654
Artigo de periodico
Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation (2020)
Horoiwa, Thais Aragão ; Cortez, Mauro ; Sauter, Ismael Pretto ; Migotto, Amanda; Bandeira, Carla Letícia ; Cerize, Natália Neto Pereira ; Oliveira, Adriano Marim de
Source: European Journal of Pharmaceutical Sciences. Unidade: ICB
Subjects: PARASITOLOGIA, LEISHMANIOSE CUTÂNEA, ANTIMÔNIO, NANOPARTÍCULAS, INFECÇÕES POR PROTOZOÁRIOS, DOENÇAS PARASITÁRIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOROIWA, Thais Aragão et al. Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation. European Journal of Pharmaceutical Sciences, v. 147, p. 9 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2020.105295. Acesso em: 01 jul. 2025.
APA
Horoiwa, T. A., Cortez, M., Sauter, I. P., Migotto, A., Bandeira, C. L., Cerize, N. N. P., & Oliveira, A. M. de. (2020). Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation. European Journal of Pharmaceutical Sciences, 147, 9 . doi:10.1016/j.ejps.2020.105295
NLM
Horoiwa TA, Cortez M, Sauter IP, Migotto A, Bandeira CL, Cerize NNP, Oliveira AM de. Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 147 9 .[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2020.105295
Vancouver
Horoiwa TA, Cortez M, Sauter IP, Migotto A, Bandeira CL, Cerize NNP, Oliveira AM de. Sugar-based colloidal nanocarriers for topical meglumine antimoniate application to cutaneous leishmaniasis treatment: Ex vivo cutaneous retention and in vivo evaluation [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 147 9 .[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2020.105295
Artigo de periodico
Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole (2020)
Passos, Julia Sapienza ; Martino, Luiza Capello de; Dartora, Vanessa Franco Carvalho; Araujo, Gabriel Lima Barros de ; Ishida, Kelly ; Lopes, Luciana Biagini
Source: European Journal of Pharmaceutical Sciences. Unidades: FCF, ICB
Subjects: MICROBIOLOGIA, FARMACOLOGIA, NANOPARTÍCULAS, ANTIFÚNGICOS, PELE, ESPOROTRICOSE, DERMATOPATIAS INFECCIOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASSOS, Julia Sapienza et al. Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole. European Journal of Pharmaceutical Sciences, v. 149, p. 11 , 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2020.105296. Acesso em: 01 jul. 2025.
APA
Passos, J. S., Martino, L. C. de, Dartora, V. F. C., Araujo, G. L. B. de, Ishida, K., & Lopes, L. B. (2020). Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole. European Journal of Pharmaceutical Sciences, 149, 11 . doi:10.1016/j.ejps.2020.105296
NLM
Passos JS, Martino LC de, Dartora VFC, Araujo GLB de, Ishida K, Lopes LB. Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 149 11 .[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2020.105296
Vancouver
Passos JS, Martino LC de, Dartora VFC, Araujo GLB de, Ishida K, Lopes LB. Development, skin targeting and antifungal efficacy of topical lipid nanoparticles containing itraconazole [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 149 11 .[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2020.105296
Artigo de periodico
Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe (2020)
Caris, Juciene Aparecida ; Benzi, Jhohann Richard de Lima ; Souza, Flávio Falcão Lima de; Oliveira, Renê Donizeti Ribeiro de; Donadi, Eduardo Antônio ; Lanchote, Vera Lucia
Source: European Journal of Pharmaceutical Sciences. Unidades: FMRP, FCFRP
Subjects: ARTRITE REUMATOIDE, METABOLISMO, ESTUDOS DE CASOS E CONTROLES, CITOCROMO P-450, ESTATINAS, NECROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARIS, Juciene Aparecida et al. Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe. European Journal of Pharmaceutical Sciences, v. 146, p. 1-7, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2020.105264. Acesso em: 01 jul. 2025.
APA
Caris, J. A., Benzi, J. R. de L., Souza, F. F. L. de, Oliveira, R. D. R. de, Donadi, E. A., & Lanchote, V. L. (2020). Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe. European Journal of Pharmaceutical Sciences, 146, 1-7. doi:10.1016/j.ejps.2020.105264
NLM
Caris JA, Benzi JR de L, Souza FFL de, Oliveira RDR de, Donadi EA, Lanchote VL. Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 146 1-7.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2020.105264
Vancouver
Caris JA, Benzi JR de L, Souza FFL de, Oliveira RDR de, Donadi EA, Lanchote VL. Rheumatoid arthritis downregulates the drug transporter OATP1B1: Fluvastatin as a probe [Internet]. European Journal of Pharmaceutical Sciences. 2020 ; 146 1-7.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2020.105264
Artigo de periodico
Changes in tramadol enantioselective pharmacokinetics and metabolism in rats with experimental diabetes treated or not with insulin (2019)
Godoy, Ana Leonor Pardo Campos; Moraes, Natália Valadares de; Benzi, Jhohann Richard de Lima ; Lanchote, Vera Lucia
Source: European Journal of Pharmaceutical Sciences. Unidade: FCFRP
Subjects: DIABETES MELLITUS, ANALGÉSICOS, GLICOSE, INSULINA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOY, Ana Leonor Pardo Campos et al. Changes in tramadol enantioselective pharmacokinetics and metabolism in rats with experimental diabetes treated or not with insulin. European Journal of Pharmaceutical Sciences, v. 128, p. 97-102, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2018.11.032. Acesso em: 01 jul. 2025.
APA
Godoy, A. L. P. C., Moraes, N. V. de, Benzi, J. R. de L., & Lanchote, V. L. (2019). Changes in tramadol enantioselective pharmacokinetics and metabolism in rats with experimental diabetes treated or not with insulin. European Journal of Pharmaceutical Sciences, 128, 97-102. doi:10.1016/j.ejps.2018.11.032
NLM
Godoy ALPC, Moraes NV de, Benzi JR de L, Lanchote VL. Changes in tramadol enantioselective pharmacokinetics and metabolism in rats with experimental diabetes treated or not with insulin [Internet]. European Journal of Pharmaceutical Sciences. 2019 ; 128 97-102.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2018.11.032
Vancouver
Godoy ALPC, Moraes NV de, Benzi JR de L, Lanchote VL. Changes in tramadol enantioselective pharmacokinetics and metabolism in rats with experimental diabetes treated or not with insulin [Internet]. European Journal of Pharmaceutical Sciences. 2019 ; 128 97-102.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2018.11.032
Artigo de periodico
Statin differentially modulate microRNAs expression in peripheral cells of hyperlipidemic subjects: a pilot study (2018)
Zambrano, Tomás; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Cerda, Alvaro; Salazar, Luís Antônio
Source: European Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: COLESTEROL, HIPERLIPIDEMIA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAMBRANO, Tomás et al. Statin differentially modulate microRNAs expression in peripheral cells of hyperlipidemic subjects: a pilot study. European Journal of Pharmaceutical Sciences, v. 117, p. 55-61, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2018.02.007. Acesso em: 01 jul. 2025.
APA
Zambrano, T., Hirata, R. D. C., Hirata, M. H., Cerda, A., & Salazar, L. A. (2018). Statin differentially modulate microRNAs expression in peripheral cells of hyperlipidemic subjects: a pilot study. European Journal of Pharmaceutical Sciences, 117, 55-61. doi:10.1016/j.ejps.2018.02.007
NLM
Zambrano T, Hirata RDC, Hirata MH, Cerda A, Salazar LA. Statin differentially modulate microRNAs expression in peripheral cells of hyperlipidemic subjects: a pilot study [Internet]. European Journal of Pharmaceutical Sciences. 2018 ; 117 55-61.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2018.02.007
Vancouver
Zambrano T, Hirata RDC, Hirata MH, Cerda A, Salazar LA. Statin differentially modulate microRNAs expression in peripheral cells of hyperlipidemic subjects: a pilot study [Internet]. European Journal of Pharmaceutical Sciences. 2018 ; 117 55-61.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2018.02.007
Artigo de periodico
Intracellular trafficking of a dynein-based nanoparticle designed for gene delivery (2018)
Favaro, Marianna Teixeira de Pinho ; Unzueta, Ugutz ; Cabo, Martí de; Villaverde, Antonio ; Ferrer-Miralles, Neus ; Azzoni, Adriano Rodrigues
Source: European Journal of Pharmaceutical Sciences. Unidade: EP
Subjects: PROTEÍNAS, NANOPARTÍCULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAVARO, Marianna Teixeira de Pinho et al. Intracellular trafficking of a dynein-based nanoparticle designed for gene delivery. European Journal of Pharmaceutical Sciences, v. 112, p. 71-78, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2017.11.002. Acesso em: 01 jul. 2025.
APA
Favaro, M. T. de P., Unzueta, U., Cabo, M. de, Villaverde, A., Ferrer-Miralles, N., & Azzoni, A. R. (2018). Intracellular trafficking of a dynein-based nanoparticle designed for gene delivery. European Journal of Pharmaceutical Sciences, 112, 71-78. doi:10.1016/j.ejps.2017.11.002
NLM
Favaro MT de P, Unzueta U, Cabo M de, Villaverde A, Ferrer-Miralles N, Azzoni AR. Intracellular trafficking of a dynein-based nanoparticle designed for gene delivery [Internet]. European Journal of Pharmaceutical Sciences. 2018 ; 112 71-78.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2017.11.002
Vancouver
Favaro MT de P, Unzueta U, Cabo M de, Villaverde A, Ferrer-Miralles N, Azzoni AR. Intracellular trafficking of a dynein-based nanoparticle designed for gene delivery [Internet]. European Journal of Pharmaceutical Sciences. 2018 ; 112 71-78.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2017.11.002
Artigo de periodico
Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models (2018)
Praça, Fabíola Silva Garcia; Medina, Wanessa Silva Garcia; Eloy, Josimar O.; Petrilli, Raquel; Campos, Patrícia Mazureki; Ascenso, Andreia; Bentley, Maria Vitória Lopes Badra
Source: European Journal of Pharmaceutical Sciences. Unidade: FCFRP
Subjects: CIÊNCIAS DA SAÚDE, PELES, CONGELAMENTO, CRIOPRESERVAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRAÇA, Fabíola Silva Garcia et al. Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models. European Journal of Pharmaceutical Sciences, v. 111, p. 121-132, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2017.09.034. Acesso em: 01 jul. 2025.
APA
Praça, F. S. G., Medina, W. S. G., Eloy, J. O., Petrilli, R., Campos, P. M., Ascenso, A., & Bentley, M. V. L. B. (2018). Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models. European Journal of Pharmaceutical Sciences, 111, 121-132. doi:10.1016/j.ejps.2017.09.034
NLM
Praça FSG, Medina WSG, Eloy JO, Petrilli R, Campos PM, Ascenso A, Bentley MVLB. Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models [Internet]. European Journal of Pharmaceutical Sciences. 2018 ; 111 121-132.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2017.09.034
Vancouver
Praça FSG, Medina WSG, Eloy JO, Petrilli R, Campos PM, Ascenso A, Bentley MVLB. Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models [Internet]. European Journal of Pharmaceutical Sciences. 2018 ; 111 121-132.[citado 2025 jul. 01 ] Available from: https://doi.org/10.1016/j.ejps.2017.09.034

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration